Our biochips were used to determine novel anti-inflammatory effects of the anti-asthma drug montelukast on resting and GM-CSF stimulated eosinophils. New drug targets were identified through eosinophil adhesion to endothelial cell markers.


Our biochips were used to study the effectiveness of the non-sedative anti-histamine drug, Levocetirizine through its effect on eosinophil adhesion to markers of the endothelial cell wall. Eosinophils migrate from blood vessels to surrounding tissue and release histamine. The side effects of the histamine release result in irritation..

Inflammation - Asthma / COPD: Eosinophil Adhesion to HMVEC-L at 0.5 dyne/cm²


A copy of this and other application notes is waiting for you, contact us at